Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Stargardt Macular Degeneration
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Choroidal Neovascularization
Journal:
Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
Treatment Used:
Ranibizumab
Number of Patients:
21
Published —
November 30, 2019
This study tested the safety and efficacy of using ranibizumab to treat patients with choroidal neovascularization.
Condition:
Stargardt Macular Dystrophy
Journal:
Nutrients
Treatment Used:
Saffron Supplements
Number of Patients:
31
Published —
October 18, 2019
The purpose of this study was to evaluate the effectiveness of saffron in improving the function of the central retina of the eye in patients suffering from Stangardt macular dystrophy.
Condition:
Dry-Type Age-Related Macular Degeneration (AMD) and Stargardt's Macular Dystrophy (SMD)
Journal:
Cellular reprogramming
Treatment Used:
Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell (ADMSC) Implantation
Number of Patients:
8
Published —
June 29, 2019
This study investigated the safety and effectiveness of suprachoroidal adipose tissue-derived mesenchymal stem cell (ADMSC) implantation in patients with dry-type age-related macular degeneration (AMD) and Stargardt's macular dystrophy (SMD).
Condition:
Spinocerebellar ataxia type 2
Journal:
Movement disorders : official journal of the Movement Disorder Society
Treatment Used:
Neurorehabilitation therapy
Number of Patients:
38
Published —
August 23, 2018
The study researched the effects of neurorehabilitation therapy for spinocerebellar ataxia type 2.
Condition:
Autosomal Recessive Stargardt Macular Dystrophy
Journal:
Ophthalmic genetics
Treatment Used:
Docosahexaenoic Acid (DHA) Supplementation
Number of Patients:
11
Published —
June 19, 2018
This study tested the effect of docosahexanoic acid (DHA) dietary supplementation on macular function in patients with Stargardt disease (a genetic eye disorder that causes progressive vision loss).
Condition:
Macular Degeneration
Journal:
Ophthalmology
Treatment Used:
Transplantation of Human Embryonic Stem Cell(hESC)-Derived Retinal Pigment Epithelial (RPE) Cells
Number of Patients:
12
Published —
June 10, 2018
This study evaluated the safety and tolerability of human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells administration in the treatment of macular degeneration.
Showing 1-6 of 6